The Do’s and Don’ts of Biotech Investor Relations and PR
Hannah Deresiewicz | EVP, Managing Director, Precision AQ Jessica Griffith | SVP, PR, Precision AQ
Nov 5, 2025
Hannah Deresiewicz | EVP, Managing Director, Precision AQ Jessica Griffith | SVP, PR, Precision AQ
Nov 5, 2025
.jpg?width=2192&height=1706&name=Claire_Blog_Post_PAQ_Site%20(1).jpg)
.png?width=2192&height=1706&name=thumb_CotM_October_MTM_capabilities%20(1).png)
.png?width=1448&height=1106&name=thumb_webinar%234_Aug_A%20(2).png)
.png?width=2192&height=1706&name=thumb_case-studies_all%20(1).png)
.png?width=400&height=300&name=Biopharma%20(1).png)
.png?width=1973&height=1533&name=thumb_visual_companies_leading_WEBINT_2024dec%20(1).png)
.png?width=1973&height=1533&name=Blog_thumb_visual_BM_correlation_2024nov%20(1).png)
.jpg?width=450&height=307&name=GettyImages-1180357582-Man_Looking_at_Laptop-RET%20(1).jpg)
-1.jpg?width=450&height=300&name=GettyImages-961222238-Patient_Family_Hugging-RET%20(1)-1.jpg)
.png?width=1973&height=1533&name=thumb_visual_global_local_WEBINT_2024dec%20(1).png)
.jpg?width=7360&height=4912&name=GettyImages-514832892-People_Conference_Room-RET%20(1).jpg)
